García PA, Zayas GM, Martínez FF

Language: Spanish
References: 17
Page: 176-181
PDF size: 313.23 Kb.

ABSTRACT

Introduction and Objective: The rational use of medicines should be based on the scientific information available about its efficacy, safety, ease of administration and cost. The objective of this study was to characterize the behavior of the use of antihy-pertensive drugs.
Method: A research on drug use, indication-prescription type, was conducted in ten family doctor offices in the health area belonging to the Capitán Roberto Fleites polyclinic in the period between July and December 2011. The sample consisted of 431 patients with hypertension, who received 680 prescriptions of antihypertensive drugs under controlled medication certificates. The variables analyzed were age, sex, pharmacological groups, antihypertensive drugs, therapeutic strategy and its classification.
Results: Female gender (54.29%) and patients over 65 years (46.17%) were the largest users of antihypertensive drugs, the most commonly used drug groups were inhibitors of angiotensin converting enzyme (68.68 %) and diuretics (64.03%), and as specific drugs, captopril (26.47%) and hydrochlorothiazide (22.35%). Combined treatment of hypertension (63.11%) was predominant and prescription errors were mainly found in the pattern of drug administration.
Conclusions: The female geriatric population was the greatest user of antihypertensive drugs. Combination therapy with two or more drugs was the most frequent and inhibitors of angiotensin converting enzyme and diuretics, the most widely used. Prescription errors were more frequent in the pattern of drug administration.

REFERENCES

1. Figueiras A, Caamaño F, Gestal Otero JJ. Metodo-logía de los estudios de utilización de medicamen-tos en atención primaria. Gac Sanit. 2000;14 (Supl 3):7-19.

2. Figueras A, Vallano A, Narváez E. Fundamentos metodológicos de los estudios de utilización de me-dicamentos. Una aproximación práctica para estu-dios en ámbito hospitalario: 2003 [sitio en internet] [citado 19 sep 2012]. Disponible en: http://www.med.unne.edu.ar/catedras/farmacologia/proyecto_adscripcion_web/biblio/manual-eum.pdf

3. Arnau JM, Vallano A. Estudios de utilización de me-dicamentos. Barcelona: Medicamento y Salud [In-ternet]; 1999 [citado 3 Mar 2012]. Disponible en: http://www.femeba.org.ar/fundacion/quienessomos/Novedades/medicamentosysalud/mysv3n27277.pdf

4. Roccella E, Kaplan N. Interpretation and evaluation of clinical guidelines. In: Izzo JL Jr, Black HR, editors. Hypertension primer: The essentials of high blood pressure: Basic science, population science, and clinical management. Philadelphia, PA: Lippincott Williams & Wilkins; 2003. p. 126-7.

5. Bustos R, Mesa A, Bustos A, Rafael Bustos Mora, López G, Gutiérrez H. Hipertensión arterial en el paciente anciano del occidente de México. Rev Cu-bana Med Gen Integr [Internet]. 2004 [citado 15 Feb 2012];20(5-6):[aprox. 4 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-21252004000500006&script=sci_arttext

6. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific re-levance of usual blood pressure to vascular morta-lity: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;(9349):1903-13.

7. Hajjar I, Kotehen TA. Trends in prevalence, aware-ness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.

8. López L, Izquierdo M, Cabrera A, Sánchez O, Rome-ro L. Hipertensión arterial. Algunas características clínico epidemiológicas. 3er Congreso Virtual de Cardiología por Internet; Set 1-Nov 30; 2003. Argentina: FAC. Disponible en: http://www.fac.org.ar/tcvc/llave/tl305/tl305.htm

9. Marrero Fuentes JJ, Martínez Calderón M, Mariol Mengana A.C, Colmenero Nariño M. Factores de riesgo de la hipertensión arterial poblado La Maya 2002. [citado: 25 Feb 2012]. Disponible en: http://www.monografias.com/trabajos28/hipertension/hipertension.shtml

10. 10.Pérez MD, Dueñas A, Alfonso J, Vázquez A, Navarro D, Hernández M, et al. Guía cubana para la prevén-ción, diagnóstico y tratamiento de la Hipertensión Arterial 2006. Ministerio de Salud Pública. [citado 25 ago 2012] Disponible en: http://www.sld.cu/galerias/pdf/servicios/hta/guia_hta_cubana__version_final_2007revisada_impresa.pdf

11. 11.Meana JL, J Parodi JC, Livia JL, Torales PR. Utiliza-ción de medicamentos antihipertensivos en pacien-tes con hipertensión arterial. Rev Posg VIa Cát Med. 2005;(152):8-12.

12. 12.González JR, Alegría E, Lozano JV, Llisterri JL, García JM, González I. Impacto de la hipertensión en las cardiopatías en España. Estudio CARDIOTENS 1999. Rev Esp Cardiol. 2001;54(2):139-49.

13. 13.Wollam GL, Tarazi RC, El Dustan HP. Diuretic poten-cy of combined hydroclorothiazide and furosemide therapy in patiens with azotemia. Am J Med.1982; 72(6):929-38.

14. 14.Gross SC, Fernández MG, Malo de Molina RR, Álvarez R, Sánchez JL. Prescripción de medica-mentos antihipertensivos en un área de salud. MEDISAN [Internet]. 2002 [citado 10 Oct 2011]; 6(2):[aprox. 4 p.]. Disponible en: http://www.bvs.sld.cu/revistas/san/vol16_2_02/san04202.htm

15. 15.Morón JF. Fármacos que actúan sobre el sistema cardiovascular. En: Furones JA. Farmacología clíni-ca. Vol. 1. La Habana: Ciencias Médicas; 2010. p. 133-47.

16. 16.Ibáñez JO. Sistema renina-angiotensina-aldostero-na. Inhibidores de la enzima de conversión. En: Malgor LA, Valsecia ME, eds. Farmacología Médica. Vol 2. Farmacología renal, cardiovascular y endo-crina; [Internet] 2010. p. 33-44 [citado 3 sep 2012]. Disponible en: http://cahuanajohn.files.wordpress.com/2009/06/2-farmacologia-5volumenes-2.pdf

17. 17.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al, and the National High Blood Pressure Education Program Coordinating Com-mittee. Seventh Report of the Joint National Com-mittee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52.